Plasma p-tau217 as a suitable biomarker for monitoring cognitive changes in Alzheimer's disease
Alzheimer's & Dementia, vol 21 (Suppl 8), e110180 · December 2025
Conference abstract presented at the Alzheimer’s Association International Conference (AAIC) 2025 and published in the Alzheimer’s & Dementia conference supplement.
Recommended citation: Biel, D., Steward, A., Dewenter, A., Dehsarvi, A., Zhu, Z., Roemer-Cassiano, S., Frontzkowski, L., Hirsch, F., Brendel, M., Franzmeier, N. (2025). Plasma p-tau217 as a suitable biomarker for monitoring cognitive changes in Alzheimer’s disease. Alzheimer’s Dement., 21: e110180.
Recommended citation
Biel, D., Steward, A., Dewenter, A., Dehsarvi, A., Zhu, Z., Roemer-Cassiano, S., Frontzkowski, L., Hirsch, F., Brendel, M., Franzmeier, N. (2025). Plasma p-tau217 as a suitable biomarker for monitoring cognitive changes in Alzheimer's disease. Alzheimer's Dement., 21: e110180.